Additionally, the HH pathway crosstalks with several signaling pathways like mTOR, MAPK, and AKT, which activate genes involved in cell survival (BCL-2), and this mechanism was described as promoting HNSCC progression [28]. The gene discussed is BCL2; the disease is head and neck squamous cell carcinoma.